[Comparative study of concentrated blood derivatives of factor VIII].

Bilten za hematologiju i transfuziju Pub Date : 1984-01-01
R Baklaja, V Miletić, M Stajić, V Cvetković, V Grozdanić
{"title":"[Comparative study of concentrated blood derivatives of factor VIII].","authors":"R Baklaja,&nbsp;V Miletić,&nbsp;M Stajić,&nbsp;V Cvetković,&nbsp;V Grozdanić","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The work presents results of the investigations of blood derivatives--F VIII concentrates: commercial cryoprecipitate, concentrate of intermediary purity and derivatives of high purity: Kriobulin--Immuno, Octobulin--Landerlan, Profilate--Alfa, Factor VIII--Behring, Hemofil--Hyland, Factorate--Armour Pharma, AHF--Kaote Cutter. The following parameters were investigated: VIII: C, VIIIR: Ag, total protein, protein electrophoresis, IgG, IgA and IgM immunoglobulins and anti-A and anti-B isoagglutinins. All derivatives except cyroprecipitate have considerably higher VIIIR: RAg value compared with VIII: C, which indicated inactivation of labile VIII: C component during concentrate preparation. Specific activity varied depending on purity of preparations, but ranged from 1,72 to 22. High isoagglutinin titer of anti-A was noted in preparations of high purity, as well as the presence of immunoglobulins. Despite considerable differences in vitro, all concentrated derivatives F VIII have similar immediate clinical effect and recovery from 0,87 to 1,36. All results indicate that new ways of derivative F VIII purification should be found with lower degree of contamination of other plasma proteins and less risk of hepatitis virus transmission. When certain indications are recognized, cryoprecipitate produced in our country in all blood transfusion services should be used.</p>","PeriodicalId":75595,"journal":{"name":"Bilten za hematologiju i transfuziju","volume":"12 2","pages":"91-103"},"PeriodicalIF":0.0000,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bilten za hematologiju i transfuziju","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The work presents results of the investigations of blood derivatives--F VIII concentrates: commercial cryoprecipitate, concentrate of intermediary purity and derivatives of high purity: Kriobulin--Immuno, Octobulin--Landerlan, Profilate--Alfa, Factor VIII--Behring, Hemofil--Hyland, Factorate--Armour Pharma, AHF--Kaote Cutter. The following parameters were investigated: VIII: C, VIIIR: Ag, total protein, protein electrophoresis, IgG, IgA and IgM immunoglobulins and anti-A and anti-B isoagglutinins. All derivatives except cyroprecipitate have considerably higher VIIIR: RAg value compared with VIII: C, which indicated inactivation of labile VIII: C component during concentrate preparation. Specific activity varied depending on purity of preparations, but ranged from 1,72 to 22. High isoagglutinin titer of anti-A was noted in preparations of high purity, as well as the presence of immunoglobulins. Despite considerable differences in vitro, all concentrated derivatives F VIII have similar immediate clinical effect and recovery from 0,87 to 1,36. All results indicate that new ways of derivative F VIII purification should be found with lower degree of contamination of other plasma proteins and less risk of hepatitis virus transmission. When certain indications are recognized, cryoprecipitate produced in our country in all blood transfusion services should be used.

[血凝因子VIII浓缩衍生物的比较研究]。
这项工作展示了血液衍生物的调查结果——fviii浓缩物:商业冷冻沉淀,中间纯度浓缩物和高纯度衍生物:Kriobulin—Immuno, Octobulin—Landerlan, Profilate—Alfa, Factor VIII—Behring, hemfile—Hyland, Factorate—Armour Pharma, AHF—kaaote Cutter。检测以下参数:VIII: C、VIII: Ag、总蛋白、蛋白电泳、IgG、IgA和IgM免疫球蛋白和抗a、抗b异凝集素。除环沉淀外,所有衍生物的viir: RAg值均高于VIII: C,表明在精矿制备过程中,不稳定的VIII: C组分失活。比活性随制剂纯度的不同而变化,但范围从1,72到22。在高纯度的制剂中注意到抗a的高异凝集素滴度,以及免疫球蛋白的存在。尽管在体外存在相当大的差异,但所有浓缩的fviii衍生物在0,87到1,36之间具有相似的直接临床效果和恢复。这些结果表明,应该寻找新的纯化方法,以降低对其他血浆蛋白的污染程度,降低肝炎病毒传播的风险。当确认某些适应症时,应在所有输血服务中使用我国生产的低温沉淀。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信